Biocross is a biotechnology company develops blood tests for the diagnosis of Alzheimer’s disease.
Biocross has raised €450k across 1 funding round from 1 investor, most recently a round in Aug 2021. Based in Boecillo, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-30 | Other | €450k |
| Centre for the Development of Industrial Technology (CDTI) |
| View deal → |
